RNS Number : 5191K
Iconic Labs PLC
25 August 2023
 

 

25 August 2023

 

Iconic Labs PLC

 

("Iconic" or the "Company")

 

 

Result of AGM

 

Iconic Labs PLC (LSE: ICON) is pleased to announce that at the Company's Annual General Meeting ('AGM') held at 3pm today, all resolutions were duly passed by way of poll.

At the meeting, inter alia, a resolution was passed which approved the consolidation of the Company's ordinary shares on a 10,000 for 1 basis, such that every 10,000 ordinary shares of £0.00001 each were consolidated into 1 ordinary share of £0.1 in nominal value.

As a result, the Company's existing issued share capital of 46,996,580,000 ordinary shares of £0.00001 was consolidated into 4,699,658 ordinary shares of £0.1, each with one voting right.  Admission in respect of such new ordinary shares will become effective and that dealings in those new ordinary shares will commence on 30 August 2023. As a result of the consolidation, the ISIN of the ordinary shares will change from GB00BD060S65 to GB00BRBJ3P08.

The above figure of 4,699,658 should be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

The results of the poll were as follows: 

 


Resolutions

For

%

Against

%

Withheld

1

To receive and adopt the accounts for the financial year ended 30 June 2021.

6,029,829,160

99.02

59,851,506

0.98

89,879,728

2

To receive and adopt the accounts for the financial year ended 30 June 2022.

6,029,829,160

99.02

59,851,506

0.98

89,879,728

3

To re-appoint Norden Audit Limited as Auditors.

6,021,542,347

98.66

81,671,752

1.34

76,346,295

4

To authorise the Directors to determine the remuneration of the Auditors.

6,000,845,301

98.32

102,368,798

1.68

76,346,295

5

To re-appoint Bradley Tyler Taylor as a Director.

6,024,039,929

98.76

75,405,149

1.24

80,115,316

6

To re-appoint David Štýbr as a Director.

6,014,911,904

98.61

84,533,174

1.39

80,115,316

7

To re-appoint Marija Hrebac as a Director.

6,004,365,470

98.44

95,079,608

1.56

80,115,316

8

To re-appoint Emmanuel Blouin as a Director.

5,994,271,904

98.28

105,173,174

1.72

80,115,316

9

Issued ordinary share capital be consolidated and divided into 4,699,658 ordinary shares of £0.1 each.

5,910,559,957

96.84

192,654,142

3.16

76,346,295

10

To authorise the Directors to allot shares up to a maximum aggregate nominal amount of £1,905,217.39.

6,012,800,530

98.52

90,413,569

1.48

76,346,295


Special Resolutions:






11

To empower the Directors to generally allot relevant equity securities under Resolution 10.

6,010,800,530

98.49

92,413,569

1.50

76,346,295

12

To authorise the Directors to make market purchases of own shares.

6,039,251,219

98.95

63,962,880

1.04

76,346,295

 

A vote withheld is not a vote in law and is not counted in the calculation of the percentage of shares voted for or against any resolution.

 

- Ends -

 

For more information, please contact:

Iconic Labs

 

Brad Taylor, Chief Executive Officer

Tel: +44 (0) 7462 156238

Novum Securities Limited

David Coffman / Daniel Harris

Tel: +44 (0) 20 7399 9400

 

Yellow Jersey PR

Sarah Hollins

Annabelle Wills

Bessie Elliot

 

Tel: +44 (0) 20 3004 9512

iconic@yellowjerseypr.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGPPUMCRUPWGAA